By Liz Jones FierceBiotech Research recently sat down with Kevin Price, CEO at Scottish Stem Cell Network, to discuss some of the exciting developments in the country’s stem cell research. Price joined the SSCN, which was launched in 2003, earlier this year. SSCN works with the Scottish stem cell community, including academic institutions, clinical and …
By Tracey Staton Teva Pharmaceutical Industries is always on the lookout for a good buy. And this time, the Israeli company is looking to build up its women’s health business, scouting about for products to help grow that segment to $1 billion in annual sales. That’s triple what Teva does in that market right now. …
By Maureen Martino Sanofi-Aventis has opened its first R&D center in China, which it hopes will allow it to tap the burgeoning Chinese pharmaceuticals market. The French drugmaker is also pursuing R&D activities in Russia, South Korea and India as part of its ongoing strategy to expand in biologics, generics and emerging markets. R&D chief Marc …
By Tracey Staton Incoming Bristol-Myers Squibb CEO Lamberto Andreotti () certainly has his work cut out for him. As several news outlets have pointed out, job No. 1 will be overcoming the loss of $11 billion in revenue to generic competition by 2016. He’s said that he’s confident BMS can do so, in part by …
